Drug Discovery Leaders Warn U.S. Cuts Endanger AI Edge
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
This section explains why investors might choose an Equal Weighted Index, focusing on balanced exposure and straightforward rebalancing.
22,679 articlesAs Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
As volatility rises and headlines loom, investors ask: is the S&P 500 headed correction? This guide breaks down what ...
SpaceX begins trading on Nasdaq, positioning Elon Musk for trillionaire status as investors bet on a bold, multi-plan...
A new ETF aims to monetize the price swings of Rocket Lab and other space names by selling weekly put spreads to fund...
As AI stocks push valuations higher, a simple growth-based framework suggests paying earnings still cheap can still w...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
Japan sees renewed toilet paper stockpiling as global oil-market jitters ripple through households. Officials urge ca...
Meta is weighing a bold bet to embed real-money wagering in its social apps. The move could unlock new revenue but ra...
SpaceX pursues space-based AI data centers ahead of a 2026 IPO, stirring talk of a market shakeout as investors weigh...
As of July 8, 2026, investors are weighing how a $300,000 portfolio can yield steady monthly income. Three clear path...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...